Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Heron Therapeutics Expects 2025 Sales Of $153M-$163M Versus Consensus Of $160.633M

Author: Benzinga Newsdesk | February 27, 2025 07:48am

Financial Guidance for 2025

Item

2025 Full-Year Guidance for Net Revenue and Adjusted EBITDA

(in millions)

Net Revenue

$153.0

to

$163.0

Adjusted EBITDA

$0.0

to

$8.0

Posted In: HRTX